Directorate General of Trade Remedies (DGTR) conducts anti-dumping investigations, under the Customs Tariff Act, 1975 and the rules made thereunder, on the basis of a duly substantiated application filed by the domestic industry alleging dumping of goods into the country causing injury to the domestic industry. The basic intent of anti-dumping measures is to eliminate injury caused to the domestic industry by the unfair trade practice of dumping and to create a level playing field for the domestic industry.

Currently, anti-dumping measures are in force on 90 products imported from the People’s Republic of China, including two pharmaceutical products.

Further, 24 anti-dumping investigations are presently in progress against the alleged dumping of imports from the People’s Republic of China.

This information was given by the Minister of Commerce and Industry, Piyush Goyal, in a written reply in the Rajya Sabha today.

Anti-dumping investigations enforce remedies against dumped imports, with measures on numerous Chinese products and additional probes ongoing. DGTR initiates and conducts anti-dumping investigations under the Customs Tariff Act, 1975 on the basis of a duly substantiated application alleging dumping and injury to the domestic industry; measures aim to eliminate injury and level the playing field. At the time of the press release, measures were in force on 90 Chinese imported products (including two pharmaceuticals) and 24 investigations against Chinese imports were ongoing.